OXIDATIVE STRESS AND ANTIOXIDANT IMBALANCE IN METABOLIC SYNDROME

Authors

  • Toirova Shahrizoda Sherzod qizi Author

Keywords:

Metabolic syndrome, oxidative stress, reactive oxygen species, antioxidant defense, insulin resistance, mitochondrial dysfunction, inflammation, endothelial dysfunction, lipid peroxidation, cardiovascular disease.

Abstract

Metabolic syndrome (MetS) is a multifactorial disorder characterized by central obesity, insulin resistance, dyslipidemia, elevated blood pressure, and chronic low-grade inflammation. Oxidative stress is considered an important mechanism linking these metabolic abnormalities to cardiovascular disease and type 2 diabetes mellitus. It occurs when reactive oxygen species (ROS) production exceeds the capacity of endogenous antioxidant defenses. In MetS, excessive nutrient availability, adipose tissue dysfunction, hyperglycemia, elevated free fatty acids, mitochondrial dysfunction, and activation of ROS-producing enzymes contribute to increased oxidative burden. Persistent oxidative stress promotes lipid, protein, and DNA damage, endothelial dysfunction, inflammation, and impaired insulin signaling. At the same time, disruption of enzymatic and non-enzymatic antioxidant defenses further compromises redox homeostasis. This review summarizes the major mechanisms of oxidative stress and antioxidant imbalance in MetS, focusing on mitochondrial ROS production, inflammation, insulin resistance, endothelial dysfunction, and oxidative stress biomarkers. The potential role of antioxidant defenses and lifestyle-based interventions in restoring redox balance is also discussed..

References

1. Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of oxidative stress in metabolic syndrome. Int J Mol Sci. 2023

24(9):7898. doi:10.3390/ijms24097898. PMID:37175603.

2. Lee H, Jose PA. Coordinated contribution of NADPH oxidase- and mitochondria-derived reactive oxygen species in metabolic syndrome and its implication in renal dysfunction. Front Pharmacol. 2021

12:670076. doi:10.3389/fphar.2021.670076. PMID:34017260.

3. Martemucci G, Fracchiolla G, Muraglia M, Tardugno R, Savina Dibenedetto R, D'Alessandro AG. Metabolic syndrome: a narrative review from the oxidative stress to the management of related diseases. Antioxidants (Basel). 2023

12(12):2091. doi:10.3390/antiox12122091. PMID:38136211.

4. Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol. 2020

21(7):363-383.

5. Niture SK, Khatri R, Jaiswal AK. Regulation of Nrf2-an update. Free Radic Biol Med. 2014

66:36-44.

6. Xu J, et al. Nuclear Factor Erythroid 2 Related Factor 2 and Mitochondria Form a Mutually Regulating Circuit in the Prevention and Treatment of Metabolic Syndrome. Antioxid Redox Signal. 2024. PMID:38183629.

7. Hurrle S, Hsu WH. The etiology of oxidative stress in insulin resistance. Biomed J. 2017

40(5):257-262. doi:10.1016/j.bj.2017.06.007. PMID:29179880.

8. Rehman K, Akash MSH. Mechanisms of generating oxidative stress and developing insulin resistance: a review. Biomed Pharmacother. 2017

86:417-425.

9. Förstermann U, Xia N, Li H. Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis. Circ Res. 2017

120(4):713-735. doi:10.1161/CIRCRESAHA.116.309326.

10. Sena CM, Pereira AM, Seiça R. Endothelial dysfunction—a major mediator of diabetic vascular disease. Biochim Biophys Acta. 2013

1832(12):2216-2231.

11. Yang X, Li Y, Li Y, Ren X, Zhang X, Hu D, et al. Oxidative stress-mediated atherosclerosis: mechanisms and therapies. Oxid Med Cell Longev. 2017

2017:1272576. PMID:28878685.

12. Laclaustra M, corella D, et al. Oxidized LDL is associated with metabolic syndrome traits independently of central obesity and insulin resistance. J Clin Endocrinol Metab. 2017. PMID:27993926.

13. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human disease. Clin Chem. 2006

52(4):601-623.

14. Interaction of homocysteine, glutathione and 8-hydroxy-2'-deoxyguanosine in metabolic syndrome progression. Free Radic Res. 2016. PMID:27751791.

15. F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers. 2005

10 Suppl 1:S10-S23. PMID:16298907.

16. Onu A, Trofin DM, Tutu A, Onu I, Galaction AI, Sardaru DP, et al. Integrative strategies for preventing and managing metabolic syndrome: the impact of exercise and diet on oxidative stress reduction—a review. Life (Basel). 2025

15(5):757. doi:10.3390/life15050757. PMID:40430185.

17. Moseley GA, Collins-Bennett KA, Kraus WE, Ross LM. Effects of amount, intensity, and mode of exercise training on the metabolic syndrome: a narrative review. Sports Med Health Sci. 2025

7(5):393-403. doi:10.1016/j.smhs.2025.03.006. PMID:40936665.

18. Moabedi M, Milajerdi A. The effect of co-administration of vitamin E and C supplements on plasma oxidative stress biomarkers and antioxidant capacity: a GRADE-assessed systematic review and meta-analysis of randomized controlled trials with meta-regression. 2025. PMID:40740780.

Published

2026-10-02